Treatment related Acute Myeloid Leukimia (IMAGE)

Institute for Research in Biomedicine (IRB Barcelona)

Treatment related Acute Myeloid Leukimia

Caption

Cancer (purple) patients exposed to chemotherapy, which damage cells DNA (orange stars), may develop treatment related Acute Myeloid Leukimia (tAMLs). Non-malignant hematopoietic cells at the time of exposure to chemotherapy are faced with a bottleneck that reduces the population, leading to the development of AML over time.

Credit

IRB Barcelona

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.

License

CC BY-NC-ND

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.